Donglin Luo
Overview
Explore the profile of Donglin Luo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
533
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luo D, Li X, Wei L, Yu Y, Hazaisihan Y, Tao L, et al.
Sci Rep
. 2024 Oct;
14(1):25239.
PMID: 39448713
Epithelial ovarian carcinoma (EOC) is the most fatal among female reproductive system tumors. The immune tumor microenvironment and ubiquitin-proteasome pathway are closely related to the proliferation, invasion, and response to...
2.
Wang Y, Luo D, Jiang H, Song Y, Wang Z, Shao L, et al.
Open Life Sci
. 2023 Aug;
18(1):20220668.
PMID: 37589007
This meta-analysis investigated the effect of physical exercise (PE) on the levels of oxidative biomarkers in randomized controlled trials (RCTs) involving healthy subjects. We searched five databases for articles until...
3.
Wang Y, Luo D, Liu J, Song Y, Jiang B, Jiang H
PLoS One
. 2023 Jun;
18(6):e0286745.
PMID: 37285331
Objective: The relationship between low skeletal muscle mass index (SMI) and all-cause mortality risk in the general adults remains unclear. Our study was conducted to examine and quantify the associations...
4.
Wang L, Chen Y, Zhao J, Luo D, Tian W
Transl Cancer Res
. 2022 Aug;
11(7):1970-1976.
PMID: 35966288
Background: The prognosis of patients with breast cancer (BRCA) is difficult to predict because of the high degree of heterogeneity and complex etiological factors. Ferroptosis, an iron-dependent, new form of...
5.
Wang Z, Li S, Wang L, Zhang S, Jiang Y, Chen J, et al.
Med Sci Monit
. 2022 Aug;
28:e937909.
PMID: 35933594
This publication has been retracted by the Editor as it erroneously describes the effects of an injectable polyacrylamide gel.Reference:Zhenxiang Wang, Shirong Li, Lingli Wang, Shu Zhang, Yan Jiang, Jinping Chen,...
6.
Li A, Hao S, Luo J, Zi Y, Lan Z, Zhou T, et al.
J Oncol
. 2022 Apr;
2022:9390539.
PMID: 35378767
Background: Cancer risks vary in different mutations. We are interested in identifying regions associated with elevated/reduced risks of breast/ovarian cancers in the Chinese population and comparing with previously reported Caucasian-based...
7.
Wan W, Ao X, Chen Q, Yu Y, Ao L, Xing W, et al.
Mol Cancer
. 2022 Feb;
21(1):60.
PMID: 35197058
Background: Continual expression of PD-L1 in tumor cells is critical for tumor immune escape and host T cell exhaustion, however, knowledge on its clinical benefits through inhibition is limited in...
8.
Tian W, Hao S, Wang L, Chen Y, Li Z, Luo D
Anticancer Drugs
. 2021 Aug;
33(1):e622-e627.
PMID: 34407046
Brain metastasis is a common cause of death in HER2-positive breast cancer patients. Currently, it is mainly treated by whole-brain radiotherapy. Pyrotinib is an irreversible pan-ErbB inhibitor, which has demonstrated...
9.
Hao S, Huang M, Tian W, Chen Y, Zhao J, Luo D
J Breast Cancer
. 2021 Jan;
23(6):656-664.
PMID: 33408891
Male breast cancer (MBC) is rare and accounts for approximately 1% of all breast cancer cases worldwide. Previous studies have suggested that several factors significantly increase the risk of MBC....
10.
Hao S, Tian W, Zhao J, Chen Y, Zhang X, Gao B, et al.
J Breast Cancer
. 2020 Sep;
23(4):373-384.
PMID: 32908788
Purpose: Real-time detection and intervention can be used as potential measures to markedly decrease breast cancer mortality. Assessment of circulating tumor DNA (ctDNA) may offer great benefits for the management...